Impact of peri-operative blood transfusion on post-operative infections after radical gastrectomy for gastric cancer: a propensity score matching analysis focusing on the timing, amount of transfusion and role of leukocyte depletion

Hua Xiao, Hu Quan, Shuguang Pan, Bin Yin, Wei Luo, Gang Huang, Yongzhong Ouyang, Hua Xiao, Hu Quan, Shuguang Pan, Bin Yin, Wei Luo, Gang Huang, Yongzhong Ouyang

Abstract

Purpose: Allogeneic blood transfusions (BTF) are sometimes inevitable during radical gastrectomy with lymphadenectomy for advanced gastric cancer. The aim of this retrospective study was to investigate the association between BTF and post-operative infections, focusing on the impact of timing, amount of transfusion and the role of leukocyte depletion.

Methods: The study cohort was 2064 patients who underwent gastrectomy for gastric cancer from November 2010 to August 2017. The association between BTF and post-operative infections was estimated by univariate and multivariate analyses after propensity score matching. Subgroup analysis was performed according to the timing and amount of transfusion, and leukocyte depletion or not.

Results: Out of a total 2064 patients, 426 (20.6%) received peri-operative BTF. After one-to-one matching, 361 pairs of patients were included for further analysis, of who 68 (9.4%) developed infections. Multivariate analysis identified that an operation time ≥ 240 min, combined multi-organ resection, BTF and BMI ≥ 25 kg/m2 were independent risk factors for post-operative infection. Patients given a high-volume (> 7.5 U), intra-operatively of leukocyte-non-depleted BTF had the highest risk of developing infections clarified by subgroup analysis.

Conclusion: Infection was the most common complication following gastrectomy for gastric cancer and BTF was identified as an independent risk factor by propensity score matching and multivariate analyses. The timing, amount of transfusion and leukocyte depletion had an impact on the incidence of infection. To decrease infection, BTF should be avoided where possible, particularly during operation, with a large amount and leukocyte-not-depleted blood.

Keywords: Gastrectomy; Gastric cancer; Infection; Transfusion.

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Figures

Fig. 1
Fig. 1
Flow-chart

References

    1. Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. J Am Coll Surg. 2014;218:1215–1222. doi: 10.1016/j.jamcollsurg.2014.02.015.
    1. Ajani JA, D’Amico TA, Almhanna K, et al. Gastric cancer, version 3. 2016, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14:1286–1312. doi: 10.6004/jnccn.2016.0137.
    1. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208. doi: 10.1097/00000542-200607000-00030.
    1. Aquina CT, Blumberg N, Probst CP, et al. Significant variation in blood transfusion practice persists following upper GI cancer resection. J Gastrointestinal Surg. 2015;19:1927–1937. doi: 10.1007/s11605-015-2903-3.
    1. Aquina CT, Blumberg N, Becerra AZ, et al. Association among blood transfusion, sepsis, and decreased long-term survival after colon cancer resection. Ann Surg. 2017;266:311–317. doi: 10.1097/SLA.0000000000001990.
    1. Bellantone R, Sitges-Serra A, Bossola M, et al. Transfusion timing and postoperative septic complications after gastric cancer surgery: a retrospective study of 179 consecutive patients. Arch Surg. 1998;133:988–992. doi: 10.1001/archsurg.133.9.988.
    1. Bernard AC, Davenport DL, Chang PK, et al. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208:931–937. doi: 10.1016/j.jamcollsurg.2008.11.019.
    1. Birgegård G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005;68(Suppl 1):3–11. doi: 10.1159/000083128.
    1. Brar SS, Seevaratnam R, Cardoso R, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer. 2012;15(Suppl 1):S100–107. doi: 10.1007/s10120-011-0074-9.
    1. Cervia JS, Wenz B, Ortolano GA. Leukocyte reduction’s role in the attenuation of infection risks among transfusion recipients. Clin Infect Dis. 2007;45:1008–1013. doi: 10.1086/521896.
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi: 10.3322/caac.21338.
    1. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20. doi: 10.1056/NEJMoa055531.
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–213. doi: 10.1097/.
    1. Ecker BL, Simmons KD, Zaheer S, et al. Blood transfusion in major abdominal surgery for malignant tumors: a trend analysis using the national surgical quality improvement program. JAMA Surg. 2016;151:518–525. doi: 10.1001/jamasurg.2015.5094.
    1. Elmi M, Mahar A, Kagedan D, et al. The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Can J Surg. 2016;59:322–329. doi: 10.1503/cjs.004016.
    1. Ferraris VA, Davenport DL, Saha SP, et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg. 2012;147:49–55. doi: 10.1001/archsurg.2011.790.
    1. Fujiya K, Tokunaga M, Mori K, et al. Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: a propensity score matching analysis. Ann Surg Oncol. 2016;23:809–816. doi: 10.1245/s10434-016-5577-5.
    1. Hirao M, Tsujinaka T, Imamura H, et al. Overweight is a risk factor for surgical site infection following distal gastrectomy for gastric cancer. Gastric Cancer. 2013;16:239–244. doi: 10.1007/s10120-012-0174-1.
    1. Horan TC, Andrus M. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–332. doi: 10.1016/j.ajic.2008.03.002.
    1. Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2014 (ver. 4) Gastric Cancer. 2017;20:1–19. doi: 10.1007/s10120-016-0622-4.
    1. Jung DH, Lee HJ, Han DS, et al. Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery. Gastric Cancer. 2013;16:377–382. doi: 10.1007/s10120-012-0196-8.
    1. Kanda M, Kobayashi D, Tanaka C, et al. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer. 2016;19:255–263. doi: 10.1007/s10120-014-0456-x.
    1. Kwon SJ. Evaluation of the 7th UICC TNM staging system of gastric cancer. J Gastric Cancer. 2011;11:78–85. doi: 10.5230/jgc.2011.11.2.78.
    1. Lee KG, Lee HJ, Yang JY, et al. Risk factors associated with complication following gastrectomy for gastric cancer: retrospective analysis of prospectively collected data based on the Clavien-Dindo system. J Gastrointest Surg. 2014;18:1269–1277. doi: 10.1007/s11605-014-2525-1.
    1. Miki Y, Makuuchi R, Tokunaga M, et al. Risk factors for postoperative pneumonia after gastrectomy for gastric cancer. Surg Today. 2016;46:552–556. doi: 10.1007/s00595-015-1201-8.
    1. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996;52:249–264. doi: 10.2307/2533160.
    1. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–462. doi: 10.1056/NEJMoa0707035.
    1. Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v38–v49. doi: 10.1093/annonc/mdw350.
    1. Squires MH, III, Kooby DA, Poultsides GA, et al. Effect of perioperative transfusion on recurrence and survival after gastric cancer resection: a 7-institution analysis of 765 Patients from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;211:767–777. doi: 10.1016/j.jamcollsurg.2015.06.012.
    1. Subramanian A, Berbari EF, Brown MJ, et al. Plasma transfusion is associated with postoperative infectious complications following esophageal resection surgery: a retrospective cohort study. J Cardiothorac Vasc Anesth. 2012;26:569–574. doi: 10.1053/j.jvca.2011.12.015.
    1. Sun C, Wang Y, Yao HS, Hu ZQ. Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and meta-analysis. Int J Surg. 2015;13:102–110. doi: 10.1016/j.ijsu.2014.11.044.
    1. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg. 1998;176:462–466. doi: 10.1016/S0002-9610(98)00245-1.
    1. Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262.
    1. Xiao H, Ouyang Y, Tang M, et al. Association of perioperative and postoperative complications after radical gastrectomy for gastric cancer. Zhonghua Yi Xue Za Zhi. 2014;94:751–754.
    1. Xiao H, Xiao Y, Quan H, et al. Intra-abdominal infection after radical gastrectomy for gastric cancer: incidence, pathogens risk factors and outcomes. Int J Surg. 2017;48:195–200. doi: 10.1016/j.ijsu.2017.07.081.
    1. Xie RF, Hu P, Wang ZC, et al. Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells. Transfusion. 2015;55:1051–1057. doi: 10.1111/trf.12952.
    1. Yang T, Lu JH, Lau WY, Zhang TY, Zhang H, Shen YN, et al. Perioprioperative blood transfusion does non influence recurrence-free and overall survival after curative resection for hepatocellular carcinoma: a propensity score matching analysis. J Hepatol. 2016;64:583–593. doi: 10.1016/j.jhep.2015.10.012.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera